REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Fundacao Antonio Prudente (Brazil)

Main Activities: Specialty (except Psychiatric and Substance Abuse) Hospitals
Full name: Fundacao Antonio Prudente Profile Updated: April 22, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Portuguese Download a sample report

Fundação Antônio Prudente, is a major center for diagnosis, treatment, education and cancer research in Latin America. Built in the early 50s, is a result of the efforts of visionaries who have joined forces to lead the first Brazilian hospital focused on chemotherapy.

Headquarters
Rua Prof Antonio Prudente 211, Liberdade
Sao Paulo; Sao Paulo; Postal Code: 01509010

Contact Details: Purchase the Fundacao Antonio Prudente report to view the information.

Website: http://www.accamargo.org.br

Basic Information
Total Employees:
Purchase the Fundacao Antonio Prudente report to view the information.
Outstanding Shares:
Purchase the Fundacao Antonio Prudente report to view the information.
Financial Auditors:
Purchase the Fundacao Antonio Prudente report to view the information.
Incorporation Date:
February 13, 1967
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after Fundacao Antonio Prudente report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency BRL. Absolute financial data is included in the purchased report.
Net sales revenue
15.1%▲
Total operating revenue
15.1%▲
Operating profit (EBIT)
377.88%▲
EBITDA
79.01%▲
Net Profit (Loss) for the Period
472.45%▲
Total assets
9.68%▲
Total equity
10.5%▲
Operating Profit Margin (ROS)
4.49%▲
Net Profit Margin
14.2%▲
Return on Equity (ROE)
7.67%▲
Debt to Equity Ratio
-0.81%▼
Quick Ratio
-0.26%▼
Cash Ratio
0.01%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo